[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":8352000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-31000.0,"OtherAssetsNoncurrent_0_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2225000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2475000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":357000.0,"OperatingIncomeLoss_2_Q2_USD":-34318000.0,"OperatingIncomeLoss_1_Q2_USD":-18642000.0,"OperatingExpenses_2_Q2_USD":38760000.0,"OperatingExpenses_1_Q2_USD":20971000.0,"NumberOfReportableSegments_2_Q2_numberOfSegments":1.0,"NonoperatingIncomeExpense_2_Q2_USD":-1450000.0,"NonoperatingIncomeExpense_1_Q2_USD":-745000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-42246000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-22653000.0,"NetIncomeLoss_1_Q2_USD":-19387000.0,"NetIncomeLoss_2_Q2_USD":-35768000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31890000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-20526000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":31163000.0,"LiabilitiesCurrent_0_Q2_USD":8841000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":135376000.0,"Liabilities_0_Q2_USD":34547000.0,"InvestmentIncomeInterest_2_Q2_USD":70000.0,"InvestmentIncomeInterest_1_Q2_USD":31000.0,"PaymentsToAcquireInvestments_2_Q2_USD":54145000.0,"InterestExpense_2_Q2_USD":1535000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":731000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q2_USD":3266000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":95153545.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":96869805.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":15000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":4274000.0,"StockholdersEquity_0_Q2_USD":100829000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.23,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q2_USD":3.03,"ShareBasedCompensation_2_Q2_USD":3378000.0,"Revenues_2_Q2_USD":4442000.0,"Revenues_1_Q2_USD":2329000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1088207000.0,"RestructuringCharges_2_Q2_USD":0.0,"RestructuringCharges_1_Q2_USD":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":28766000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":15396000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":6779000.0,"ProceedsFromStockPlans_2_Q2_USD":247000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":223000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":34350000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":30693000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3789000.0,"PreferredStockSharesOutstanding_0_Q2_shares":1164000.0,"PreferredStockSharesIssued_0_Q2_shares":1164000.0,"PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount_0_Q2_USD":155886000.0,"PreferredStockDividendsAndOtherAdjustments_2_Q2_USD":6478000.0,"PreferredStockAccretionOfRedemptionDiscount_1_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":95153545.0,"InterestExpense_1_Q2_USD":763000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-118000.0,"CommonStockSharesIssued_0_Q2_shares":97700016.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-21297000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":30954000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":121300000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":30954000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":4249000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":823000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":42906000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":47425000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":47400000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":19000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":6000.0,"AssetsCurrent_0_Q2_USD":83466000.0,"Assets_0_Q2_USD":135376000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":35400000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3378000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1743000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1758000.0,"AdditionalPaidInCapital_0_Q2_USD":63933000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-48199000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":8499000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":443000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-453000.0,"AccountsReceivableNetCurrent_0_Q2_USD":1298000.0,"AccountsPayableTradeCurrent_0_Q2_USD":2063000.0,"CommonStockSharesOutstanding_0_Q2_shares":97700016.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":441000.0,"CommonStockValue_0_Q2_USD":1017416000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-35796000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-14000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-582000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-35768000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-19387000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8292000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4445000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":-44000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":15000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-13000.0,"EquityMethodInvestments_0_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-44000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.44,"EarningsPerShareDiluted_1_Q2_USD":-0.23,"EarningsPerShareBasic_1_Q2_USD":-0.23,"EarningsPerShareBasic_2_Q2_USD":-0.44,"DividendsPreferredStockCash_2_Q2_USD":6478000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":879000.0,"Depreciation_2_Q2_USD":879000.0,"Depreciation_1_Q2_USD":436000.0,"DebtSecuritiesRealizedGainLoss_2_Q2_USD":0.0,"DebtSecuritiesRealizedGainLoss_1_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2_Q2_USD":-28000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q2_USD":-31000.0,"DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_0_Q2_USD":42925000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":47419000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-19418000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":96869805.0,"Ticker":"ABUS","CIK":"1447028","name":"ARBUTUS BIOPHARMA CORP","OfficialName":"Arbutus Biopharma Corporation Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"388180699.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]